Medicine composition for regulating blood fat
A technology for regulating blood lipids and compositions, applied in the field of medicine, can solve the problems of easy rebound of blood lipids and the like, and achieve the effect of regulating blood lipids with strong biological activity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
experiment example 1
[0019] Experimental Example 1 The preparation method of each compound of the present invention:
[0020] Experimental materials, instruments and reagents
[0021] The aerial part of Dioscorea nipponica Makino was collected from Jingyu County, Jilin Province, and was identified as the aerial part of Dioscorea nipponica Makino by Professor Zhang Jimin, Department of Pharmacognosy, School of Pharmacy, Jilin University.
[0022] Silica gel (400-500 mesh) for column chromatography is a product of Qingdao Ocean Chemical Factory, and silica gel plate (100mm×100mm) for thin-layer chromatography is a product of Qingdao Ocean Chemical Factory. The filler used in the atmospheric pressure ODS column was produced by Tianjin Chemical Reagent Factory Chromatography Technology Development Company. All reagents used are of analytical grade, and petroleum ether is in the middle boiling range (60°C-90°C). Xinhua No.1 filter paper was used for paper chromatography. Thin-layer chromatography us...
experiment example 2
[0060] Experimental example 2 The present invention is to the impact test of hyperlipidemia mouse blood lipid
[0061] Materials and Methods
[0062] Animals 120 ICR mice, 80 males and 40 females, weighing 18-20 g. Purchased from the Animal Experiment Center of Jilin University School of Basic Medicine, animal certificate number: SCXK-(Ji)-2003-0001. Drugs and reagents Xuezhikang Capsules, specification: 300mg / capsule, batch number 20060305, produced by Beijing Beida Weixin Biotechnology Co., Ltd.;
[0063] Fenofibrate group, specification: 200mg / capsule, batch number 89396, produced by French Liboforni Pharmaceutical Company;
[0064] Cholesterol, specification: biochemical reagent, 25g / bottle, lot number: 070516, Tianjin Guangfu Fine Chemical Research Institute;
[0065] Sodium cholate, specification: biochemical reagent, batch number: 20070525, Beijing Chemical Reagent Company;
[0066] Lard, provided by the laboratory;
[0067] Serum Total Cholesterol (TC) Content Det...
experiment example 3
[0096] The preparation of experimental example 3 granules of the present invention
[0097] It is composed of the following compounds by weight percentage:
[0098] 3,7-Dihydroxy-2,4,6-trimethoxyphenanthrene 15%,
[0099] 1-(2,7-dihydroxy-4,6-dimethoxyphenanthrene)-2,7-dihydroxy-4,6-dimethoxyphenanthrene 15%,
[0100] 7-Hydroxy-2,6-dimethoxy-1,4-phenanthrenequinone 10%,
[0101] Kaempferol-3-O-β-D-glucopyranoside 15%
[0102] Kaempferol-3-O-β-rutinoside 15%
[0103] Rutin 35%.
[0104] The above-mentioned compound is added with conventional auxiliary materials for preparing granules to prepare granules.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com